Arusha Ayub | Medicine | Best Researcher Award

Published on by Academic Excellence

Ms. Arusha Ayub | Medicine | Best Researcher Award

University of Georgia | Georgia

Arusha Ayub is a dedicated final-year medical student at the University of Georgia, pursuing a Doctor of Medicine (MD) degree at the College of Health Sciences. Her academic journey began at the International Indian Embassy School in Riyadh, Saudi Arabia, where she completed both her secondary (2018) and senior secondary (2020) education under the CBSE board. Driven by a passion for advancing clinical and translational medicine, she has actively engaged in impactful research at both the University of Georgia and King Saud University. At the Scientific Research Institute, University of Georgia, Arusha has contributed as a research assistant to the project “Epidemiological Assessment of Living Indicators According to Systems in the Last Days of Life of Patients in the Terminal Phase of Cancer.” Her work focuses on assessing nutrition and gastrointestinal function in terminal cancer patients using a variety of standardized clinical assessment tools, thereby enhancing understanding of end-of-life care and patient quality of life. In addition, Arusha serves as a research intern under the mentorship of Dr. Sultan Meo at King Saud University, Riyadh. Her role involves participation in clinical studies emphasizing real-world data, study design, data collection, analysis, and manuscript development. Through collaboration with multidisciplinary teams, she has demonstrated excellence in research integrity, clinical evaluation, and scientific communication. Arusha’s academic rigor and research engagement reflect her commitment to integrating evidence-based medicine with compassionate healthcare practice, positioning her as a promising future physician and medical researcher.

Profile:  Google Scholar

Featured Publication

1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al‐Abbasi, F. A., et al. (2025). STAT3 signaling pathway in health and disease. MedComm, 6(4), e70152.

2. Ayub, A., Sultana, N., Faruk, M. I., Rahman, M. M., & Mamun, A. N. M. (2009). Control of rhizome rot disease of ginger (Zingiber officinale Rose) by chemicals, soil amendments, and soil antagonists. The Agriculturists, 12, 57–61.

3. Sultana, N., Ayub, A., & Islam, M. (2008). Yield loss assessment of onion bulb due to purple blotch disease. Annual Research Report, Plant Pathology Division, Bangladesh Agricultural Research Institute (BARI), Joydevpur.

4. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.

5. Latif, M., Hashmi, J. A., Alayoubi, A. M., Ayub, A., & Basit, S. (2024). Identification of novel and recurrent variants in BTD, GBE1, AGL and ASL genes in families with metabolic disorders in Saudi Arabia. Journal of Clinical Medicine, 13(5), 1193.

Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Published on by Academic Excellence

Prof. Dr. Inamul Hasan Madar | Medicine | Outstanding Scientist Award

Prof. Dr. Inamul Hasan Madar | Medicine | Yenepoya Universtiy |India

Dr. Inamul Hasan Madar is a distinguished researcher and educator in the field of biochemistry with a specialization in oncology proteogenomics. He earned his PhD from Korea University, a globally ranked institution, and has since developed extensive expertise in cancer genomics, multiomics integration, and bioinformatics. With a strong commitment to advancing medical research, Dr. Madar has served as an adjunct faculty at Saveetha Medical College (SIMATS), where he has mentored PhD, MD, MBBS, and MSc students in cutting-edge biomedical sciences. His international research experience includes appointments at Korea University and Hanyang University in South Korea, where he contributed to high-impact oncology projects. As Director and Lead of Canary Oncoceutics India, he has bridged the gap between research and industry by leading innovative onco-therapeutic initiatives. Widely published in top-tier journals, Dr. Madar has also served as a reviewer for international journals and as a member of prestigious scientific societies worldwide.

Author profile

Orcid

Education

Dr. Madar’s academic journey reflects a deep pursuit of excellence in biomedical sciences. He earned his PhD in Biochemistry, specializing in Onco-Proteogenomics, from Korea University, Seoul, ranked among the top global universities. His doctoral work focused on proteogenomic profiling and cancer biomarker discovery, positioning him at the forefront of precision oncology. Before this, he pursued advanced training in bioinformatics, molecular biology, and proteomics, equipping him with multidisciplinary skills to tackle complex biomedical challenges. His postgraduate education emphasized molecular diagnostics and computational approaches, while his undergraduate studies laid the foundation in biochemistry and clinical applications. Dr. Madar has also completed specialized training programs in next-generation sequencing (NGS), computational modeling, molecular docking, and drug discovery pipelines. Furthermore, he has been actively engaged in faculty development programs, including pedagogy training for undergraduate teaching in life sciences and biotechnology. This comprehensive educational background underscores his ability to combine research innovation with academic excellence.

Experience

Dr. Madar’s professional experience spans academia, research, and industry. He currently serves as Adjunct Faculty at Saveetha Medical College, SIMATS, where he mentors MBBS, MD, MSc, MPhil, and PhD students in research methodologies, cancer biology, and bioinformatics. He is also Director and Lead (Marketing) at Canary Oncoceutics India, overseeing translational oncology research and innovation in oncoceutical product development. Internationally, he worked as a Visiting Scientist at Korea University, specializing in proteogenomics, and as a Researcher at Hanyang University, Seoul, in bioengineering. In India, his previous roles include Scientist & Course Coordinator at Biocuration, where he designed genomics and drug development modules, and Junior Scientist at iPro Technologies. He has also contributed as a guest lecturer at Bharathidasan University, training future biochemists. His expertise extends to designing computational pipelines, analyzing multiomics datasets, and leading cross-disciplinary projects that bridge laboratory science and clinical application, particularly in cancer therapeutics and biomarker discovery.

Awards and Honors

Dr. Inamul Hasan Madar has received widespread recognition for his contributions to biomedical research and education. His publications in high-impact journals such as Nature Cancer, Oncotarget, Briefings in Bioinformatics, and Molecular Cancer have positioned him among leading voices in proteogenomics and cancer research. He has served as a peer reviewer for several prestigious journals, including Nature’s Scientific Reports, Frontiers in Oncology, BMC Medical Genomics, and Journal of Translational Medicine. He has been actively involved in international professional societies, including the American Association of Cancer Research (AACR), American Society for Biochemistry and Molecular Biology (ASBMB), International Society of Computational Biology (ISCB), and South African and Korean Mass Spectrometry Societies. His leadership roles include serving as Vice President of ISCB-RSG India, demonstrating his dedication to strengthening scientific networks. He has also mentored numerous graduate and medical students, guiding them to publish impactful research, file patents, and develop translational medical applications.

Research Focus

Dr. Madar’s research focus lies at the intersection of cancer genomics, proteogenomics, and computational biology. He specializes in integrating multiomics datasets to identify novel biomarkers and therapeutic targets for treatment-resistant cancers, particularly cervical, prostate, and oral squamous cell carcinoma. His expertise in next-generation sequencing (RNA-Seq, Exome-Seq) and bioinformatics has enabled him to develop innovative pipelines for cancer biomarker discovery, molecular subtyping, and clinical variant interpretation. Beyond oncology, he has contributed to research in neurobiology, metabolic disorders, cardiovascular protection, and bioactive peptides against diabetes and obesity. His translational approach emphasizes the “bench-to-bedside” concept, applying computational models and molecular profiling to guide precision medicine strategies. Dr. Madar has also explored theranostic targets, signaling networks, and novel oncoceutical formulations. His interdisciplinary collaborations with international research groups have advanced drug design, CAR-T therapy applications, and personalized treatment strategies, positioning him as a pioneer in cancer research and translational medicine.

Publications

  • Correction to: Proteogenomic characterization of molecular and cellular targets for treatment-resistant cervical cancers.

  • Molecular analysis of HPV16 and HPV18 oncogenes in oral squamous cell carcinoma.

  • Proteogenomic characterization of treatment-resistant subtypes in cervical cancers.

  • Theranostic Target NSUN2 uncovered with systematic assembly of 805 datasets.

  • Unravelling the phosphoregulatory network of PKC-delta (PKC-δ).

  • BDNF-TrkB signalling: A neurotrophic pathway to cardiovascular protection.

  • Physiological activities of bioactive peptides against diabetes and obesity.

  • SGLT2 inhibitors as dual therapeutic targets for cardiovascular and renal health.

  • Biobased nanomaterials and rhizobacteria for sustainable plant growth.

  • CAR-T therapy in oral squamous cell carcinoma: Current innovations and future prospects.

Conclusion

Dr. Inamul Hasan Madar exemplifies excellence in translational medicine, combining cutting-edge cancer research with dedicated academic mentorship. His impactful publications, international collaborations, and leadership in oncology research position him as a transformative figure in biomedical sciences. Through his expertise in proteogenomics and bioinformatics, he continues to advance precision medicine while inspiring the next generation of medical researchers.

Afra Wasama Islam | Medicine | Academic Excellence Award

Published on by Academic Excellence

Ms. Afra Wasama Islam | Medicine | Academic Excellence Award

Ms. Afra Wasama Islam | Medicine | Faculty of Medicine, Tbilisi State Medical University | Georgia

Afra Wasama Islam is a dedicated 5th-year medical student at Tbilisi State Medical University, Georgia, with a strong passion for clinical practice and medical research. She combines technical proficiency in clinical examination, surgical skills, and pharmacotherapy with advanced competencies in wet lab techniques such as ELISA, PCR, and microscopy. As the Chief Executive Officer of ClinNova International, Afra leads a team of over 70 individuals, demonstrating her leadership and management expertise alongside her academic achievements. She actively contributes to global medical communities through her involvement in research clubs, webinars, workshops, and scientific presentations. With publications in international journals and recognition for her work on gastrointestinal health, infectious diseases, and cardiovascular research, she is establishing herself as a promising medical researcher. Her diverse interests, multilingual abilities, and strong creative outlook further complement her vision of advancing healthcare research and practice on a global scale.

Author Profile

Orcid

Education 

Afra Wasama Islam is pursuing her Bachelor of Medicine, Bachelor of Surgery (MBBS) at Tbilisi State Medical University, Georgia, where she is currently in her 5th year of studies (2021–2027). Her academic journey reflects a strong commitment to excellence in both theoretical knowledge and hands-on training. She has acquired comprehensive exposure to medical history-taking, clinical examinations, pharmacotherapy, and advanced surgical procedures. Afra has further strengthened her academic foundation through certifications in Good Clinical Practice (GCP), NIH’s IPPCR course, Basic Surgical Skills, Basic and Pediatric Advanced Life Support, and Healthcare Communication. These achievements demonstrate her dedication to maintaining high standards in medical ethics, patient care, and research methodologies. Her education is also enriched by global exposure, as she participates in international webinars, workshops, and presentations, gaining cross-cultural medical perspectives. With her academic rigor and continuous learning, Afra is well-prepared to contribute significantly to clinical medicine and research innovation.

Experience

Afra’s professional experience highlights her dual strengths in clinical research and leadership. As the CEO of ClinNova International, she manages and mentors a team of 70+, leading global collaborations in medical research. She also serves as a Research Mentor at ClinAcademy and ClinNova International, nurturing future medical researchers. Her leadership extends to positions such as Head of the Creative Department at GCMER Georgia, Co-Head of Workshops at IJCR, and Secretary of the Social Media Chapter at YCC, where she has supervised and trained diverse teams. Afra has actively contributed to academic communities as a Webinar Host for SSSG and a Core Team member of the Research Club at TSMU. Beyond management, she has presented her research at multiple international conferences, covering topics from oncology to robotic surgery. This blend of organizational leadership, clinical knowledge, and academic research positions her as a versatile and impactful emerging medical professional.

Awards and Honors 

Afra Wasama Islam has been recognized for her academic excellence and scientific contributions through various awards and honors. She has presented her research at prestigious platforms such as Eternity (Tbilisi, Georgia), Pulmora, and the Royal Society of Medicine (UK), where her work on topics including lung cancer surgery, spinal cord injury, robotic mastectomy, and stroke prevention has gained significant attention. Her oral and poster presentations reflect her dedication to advancing clinical understanding and innovative practices in medicine. She has also been honored with leadership responsibilities across organizations like ClinNova International, IJCR, and GCMER, highlighting her role as a young leader in medical research. Afra’s certifications from renowned institutions, including the National Institute of Health (NIH) and Clinical Skills Centers, further reinforce her credibility. Her professional memberships with international medical societies showcase her global recognition and commitment to collaborative medical advancement.

Research Focus 

Afra Wasama Islam’s research focus integrates clinical medicine, public health, and translational science. She has explored diverse areas such as neuropsychiatric disorders (Depersonalization-Derealization Disorder), gastrointestinal health (FODMAP diets in IBS patients), and infectious diseases (human metapneumovirus and measles). Her cardiovascular research investigates the implications of L-carnitine and TMAO in heart complications, while her public health studies address zoonotic viral transmission and healthcare strategies. Beyond disease mechanisms, Afra is passionate about digital health, demonstrated in her work on smart inhalers for asthma and COPD, combining medicine with technological innovation. She has also contributed to research on surgical innovations, including robotic versus open mastectomy and thoracotomy versus minimally invasive surgery. This diverse portfolio reflects her forward-looking vision of bridging clinical practice, research, and digital healthcare solutions. With her strong multidisciplinary foundation, Afra aims to contribute to patient-centered healthcare, medical innovation, and global public health improvement.

Publications 

  1. Depersonalization-Derealization Disorder: Etiological Mechanism, Diagnosis and Management.

  2. Comparison of Impact of High vs. Low FODMAP Diet on Gut Flora in IBS Patients.

  3. Clinical Implications of L-Carnitine and Elevated TMAO in Cardiovascular Complications.

  4. Clinical Insights in Human Metapneumovirus Management and Prognosis.

  5. Potential Zoonotic Transmission of HKU5-CoV-2: Host Susceptibility & Public Health Risks.

  6. Comprehensive Review of Measles: Outbreaks, Clinical Manifestations & Therapies.

Conclusion

Afra Wasama Islam exemplifies the qualities of a future leader in medicine combining clinical acumen, innovative research, and effective leadership. With her international publications, research presentations, and executive experience in medical organizations, she has established herself as a promising young professional. Her focus on integrating clinical practice, research, and digital health innovation positions her to make impactful contributions to global healthcare. She is highly suitable for recognition under the Medicine Award, as her work reflects both academic excellence and dedication to advancing human health.